NAD Refers Mask, LLC to FTC After Company Declines to Comply with Recommendations for Spotless Blemishes & Oily Skin Soothing CBD Sheet Mask
Contact: Abby Hills, Director of Communications, BBB National Programs
703.247.9330 / firstname.lastname@example.org
New York, NY – September 24, 2020 – The National Advertising Division (NAD) of BBB National Programs has referred advertising claims made by Mask, LLC to the Federal Trade Commission (FTC) for review after the company declined to comply with NAD’s recommendations to discontinue the product name “Spotless Blemishes & Oily Skin Soothing CBD Sheet Mask,” as well as the claim “Helichrysum Essential Oil may work to help heal blemishes, encouraging signs of skin renewal and cell turnover to lessen the look of redness and scarring.”
Through its routine monitoring program, NAD requested substantiation for the following express claims:
Spotless Acne & Psoriasis Sheet
- “Spotless Acne & Psoriasis Sheet”
- “This full-spectrum CBD-infused sheet masks calms signs of inflammation, returning skin to a calmer, clearer state.”
- “This solution works to help heal acne and psoriasis, encouraging signs of skin renewal and cell turnover to lessen the look of redness and scarring.”
Spotless Blemishes & Oily Skin Soothing CBD Sheet Mask
- “Spotless Blemishes & Oily Skin Soothing CBD Sheet Mask”
- “Helichrysum Essential Oil may work to help heal blemishes, encouraging signs of skin renewal and cell turnover to lessen the look of redness and scarring.”
NAD noted that the product name, Spotless Blemishes & Oily Skin Soothing CBD Sheet Mask, expressly claims that the mask confers two benefits: (1) spotless blemishes; and (2) soothes oily skin. NAD recommended that the product name be discontinued because the advertiser did not conduct or provide any testing on the product itself to support these product performance claims.
Further, NAD determined that the advertiser failed to provide a reliable ingredient study demonstrating that the amount of helichrysum essential oil found in the product (which the advertiser never specified) has a positive effect on blemishes. Therefore, NAD recommended that the claim “Helichrysum Essential Oil may work to help heal blemishes, encouraging signs of skin renewal and cell turnover to lessen the look of redness and scarring” be discontinued.
Finally, NAD noted that it appears that the Spotless Acne & Psoriasis Sheet product originally marketed is now being sold under a different name with modified claims. NAD did not review the product name and originally challenged claims on their merits.
In its advertiser’s statement, Mask stated that it will not comply with NAD’s recommendations. The advertiser stated that it believes “there is no basis to conclude that the product claims to remove blemishes simply because the word ‘spotless’ is in the product name.” Further, the advertiser stated that “at no time does MASK Skincare claim that Helichrysum Essential Oil absolutely and without qualification has a beneficial or positive effect on the skin.”
Considering the advertiser’s decision, NAD has referred the matter to the attention of the appropriate government agency for possible enforcement action.
About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.
About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.
Children’s Advertising Review Unit Determines Development Platform Unity Did Not Have Actual Knowledge of Ad SDK Data Collection in Child-Directed Apps
McLean, VA – April 28, 2021 – The Children’s Advertising Review Unit (CARU), a division of BBB National Programs, determined that Unity Technologies did not have actual knowledge, as defined by the Children’s Online Privacy Protection Act (COPPA) and CARU’s Guidelines for Online Privacy...
National Advertising Division Recommends Charter Communications Discontinue Spectrum Mobile “Fastest Overall Speeds” Nationwide Claim; Advertiser to Appeal
New York, NY – April 27, 2021 – The National Advertising Division (NAD) determined that evidence offered by Charter Communications to support its claim that Spectrum Mobile delivers the “fastest overall speeds” nationwide was not a good fit. In recommending that the claim be...
National Advertising Division Recommends Natural Diamond Council Discontinue Certain Advertising Claims on Benefits of Mined Versus Man-Made Diamonds
New York, NY – April 22, 2021 – The National Advertising Division (NAD) recommended that the Natural Diamond Council discontinue certain advertising claims comparing mined diamonds with man-made diamonds, including the carbon emissions associated with diamond mining compared with diamond...
DSSRC Refers Health-Related Product and Earnings Claims for Bulavita to FTC
McLean, VA – April 20, 2021 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs referred certain representative product performance and earnings claims to the Federal Trade Commission (FTC) for possible enforcement action after Bulavita failed to respond to DSSRC’s inquiry.